COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
78.04 EUR
+0.22 (+0.28%)
Taking everything into account, CBHD scores 5 out of 10 in our fundamental rating. CBHD was compared to 63 industry peers in the Health Care Equipment & Supplies industry. CBHD scores excellent on profitability, but there are some minor concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
CBHD had a positive operating cash flow in the past year.
In the past 5 years CBHD has always been profitable.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of CBHD (7.52%) is better than 80.95% of its industry peers.
CBHD's Return On Equity of 22.55% is amongst the best of the industry. CBHD outperforms 92.06% of its industry peers.
With an excellent Return On Invested Capital value of 12.65%, CBHD belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is above the industry average of 9.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD has a better Profit Margin (13.04%) than 74.60% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
CBHD's Operating Margin of 27.52% is amongst the best of the industry. CBHD outperforms 95.24% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
CBHD has a Gross Margin of 67.97%. This is in the better half of the industry: CBHD outperforms 74.60% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
CBHD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CBHD remains at a similar level compared to 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CBHD has been reduced compared to a year ago.
2.2 Solvency
CBHD has an Altman-Z score of 3.99. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD's Altman-Z score of 3.99 is fine compared to the rest of the industry. CBHD outperforms 69.84% of its industry peers.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.34, CBHD is doing good in the industry, outperforming 61.90% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CBHD (1.24) is worse than 82.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.99 |
ROIC/WACC2.2
WACC5.76%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD has a Current ratio (1.61) which is in line with its industry peers.
A Quick Ratio of 1.00 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD's Quick ratio of 1.00 is in line compared to the rest of the industry. CBHD outperforms 41.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -20.93% in the last year.
Measured over the past years, CBHD shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.02% on average per year.
The Revenue has been growing slightly by 3.12% in the past year.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.49% on average per year.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
The Earnings Per Share is expected to grow by 17.18% on average over the next years. This is quite good.
CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.53% yearly.
EPS Next Y45.69%
EPS Next 2Y27.02%
EPS Next 3Y23.6%
EPS Next 5Y17.18%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.79 indicates a quite expensive valuation of CBHD.
CBHD's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 25.65. CBHD is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 22.53, which indicates a rather expensive current valuation of CBHD.
The rest of the industry has a similar Price/Forward Earnings ratio as CBHD.
CBHD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.79 | ||
| Fwd PE | 22.53 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is in line with the industry average.
76.19% of the companies in the same industry are more expensive than CBHD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.48 | ||
| EV/EBITDA | 15.81 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBHD has a very decent profitability rating, which may justify a higher PE ratio.
CBHD's earnings are expected to grow with 23.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y27.02%
EPS Next 3Y23.6%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.99%.
Compared to an average industry Dividend Yield of 2.22, CBHD pays a better dividend. On top of this CBHD pays more dividend than 98.41% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CBHD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.99% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y27.02%
EPS Next 3Y23.6%
FRA:CBHD (11/24/2025, 7:00:00 PM)
78.04
+0.22 (+0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.40B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts68.46
Price Target93.67 (20.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.99% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.89%
PT rev (3m)-3.26%
EPS NQ rev (1m)13.74%
EPS NQ rev (3m)11.87%
EPS NY rev (1m)-1.05%
EPS NY rev (3m)-3.53%
Revenue NQ rev (1m)6.06%
Revenue NQ rev (3m)4.69%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-1.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.79 | ||
| Fwd PE | 22.53 | ||
| P/S | 4.4 | ||
| P/FCF | 23.48 | ||
| P/OCF | 18.44 | ||
| P/B | 7.6 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.81 |
EPS(TTM)2.38
EY3.05%
EPS(NY)3.46
Fwd EY4.44%
FCF(TTM)3.32
FCFY4.26%
OCF(TTM)4.23
OCFY5.42%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.72
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.99 |
F-Score6
WACC5.76%
ROIC/WACC2.2
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y45.69%
EPS Next 2Y27.02%
EPS Next 3Y23.6%
EPS Next 5Y17.18%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year28.29%
EBIT Next 3Y15.9%
EBIT Next 5Y12.37%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 45.69% in the next year.